stockrow
Friday 6 November 2026
Export SKIN’s income statement to Excel — free account
SkinHealth Systems Inc.
SKIN Consumer Defensive Household & Personal Products
SkinHealth Systems Inc.’s revenue for fiscal 2025 (year ended December 2025) was $300.8 million, down 10.0% from fiscal 2024.
- Revenue
- −2.10%
- EPS
- −112.5%
- Free cash flow
- +19.1%
- Total debt
- −33.1%
Quarter to September 2026, against a year earlier
15.79
5.44
+52.56%
Follow SKIN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | — |
| (16.87%) | (11.95%) | (43.89%) | (30.13%) | ||
| (1.61%) | (1.06%) | (5.72%) | (4.10%) | ||
ROIC |
(6.74%) | (3.39%) | (1.38%) | 2.32% | |
Return on Tangible Assets |
(7.57%) | (4.85%) | (22.02%) | (13.69%) | |
Average Days of Receivables |
28.44 | 24.96 | 24.71 | 25.68 | |
Free Cash Flow per Share |
5.12 | 3.64 | 2.57 | 0.00 | |
Free Cash Flow |
32.32 | 23.27 | 16.64 | 18.28 | |
Capital Expenditures |
(5.16) | (5.67) | (5.32) | (5.30) | |
| Other line items | |||||
Cash ROIC |
4.91% | 3.85% | 2.74% | 4.45% | |
Accounts Receivable Turnover |
11.59 | 13.53 | 12.41 | 12.63 | |
Accounts Payable Turnover |
5.56 | 5.32 | 5.00 | 5.84 | |
Inventory Turnover |
1.78 | 1.83 | 1.84 | 1.85 | |
Average Days of Payables |
54.64 | 55.81 | 60.03 | 58.21 | |
Days of Inventory on Hand |
167.82 | 167.55 | 175.18 | 178.44 | |
Tax Rate |
0.60 | 0.71 | 0.20 | 0.39 | |
Research and Development Expense of Revenue |
1.87% | 1.94% | 2.03% | 2.03% | |
Selling, General and Administrative Expense of Revenue |
70.33% | 66.55% | 65.81% | 62.79% | |
Share Based Compensation of Revenue |
4.93% | 4.53% | 3.80% | 3.47% | |
Interest Coverage |
(1.08) | (0.46) | (0.17) | 0.27 | |
Operating CF/Net income |
(3.94) | (4.78) | (0.77) | (1.29) | |
Depreciation/Fixed assets |
11.42 | 12.15 | 13.60 | 0.00 | |
Capex/Depreciation |
(0.18) | (0.20) | (0.19) | 0.00 | |
Revenue per Share |
47.60 | 46.34 | 44.76 | 0.00 | |
Operating CF per Share |
5.93 | 4.53 | 3.39 | 0.00 | |
Capex per Share |
(0.82) | (0.89) | (0.82) | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026